Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Sting challenge: indications and execution].

F Ruëff1, B Przybilla

  • 1Klinik und Poliklinik für Dermatologie und Allergologie, Ludwig-Maximilians-Universität, Frauenlobstr. 9-11, 80337, München, Deutschland, Franziska.Rueff@med.uni-muenchen.de.

Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|September 20, 2014
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Atopy patch testing with aeroallergens in a large clinical population of dermatitis patients in Germany and Switzerland, 2000-2015: a retrospective multicentre study.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Same author

Contraindications to immunotherapy: a global approach.

Clinical and translational allergy·2019
Same author

Food-induced anaphylaxis and cofactors - data from the anaphylaxis registry.

Allergologie select·2018
Same author

Risk factors in Hymenoptera venom allergy.

Allergologie select·2018
Same author

The urgent need for a harmonized severity scoring system for acute allergic reactions.

Allergy·2018
Same author

Factors increasing the risk for a severe reaction in anaphylaxis: An analysis of data from The European Anaphylaxis Registry.

Allergy·2018
Same journal

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Viral infections of the skin].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Viral exanthems in children].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Erratum to: Digital health applications and data protection].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Virus-induced exanthems in returning travellers].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Venous ulcus cruris-Surgical treatment].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
See all related articles

The sting challenge test is the only reliable way to check if venom immunotherapy (VIT) is protecting Hymenoptera venom allergy patients. It helps identify those not protected, improving their quality of life.

Area of Science:

  • Allergy and Immunology
  • Clinical Medicine

Context:

  • Venom immunotherapy (VIT) effectively treats Hymenoptera venom allergy but may not always prevent systemic reactions.
  • Current in vitro parameters and skin tests do not reliably predict clinical reactivity during VIT.
  • The sting challenge test remains the definitive method for assessing clinical reactivity in sensitized patients.

Purpose:

  • To define the indications, contraindications, and performance of sting challenge tests in managing venom allergy.
  • To evaluate the role of sting challenges in identifying patients with inadequate protection from VIT.
  • To assess factors influencing treatment failure and protection rates in VIT.

Summary:

  • Sting challenge tests are indicated for identifying patients unprotected by VIT and for quality of life improvement, but not for routine diagnostics or in patients not undergoing VIT.

Related Experiment Videos

  • Contraindications include repeated side effects during maintenance VIT or unstable medical conditions. Risk factors for treatment failure include mastocytosis, bee venom allergy, and ACE inhibitors.
  • Higher venom doses, double VIT, and longer treatment durations correlate with significantly better protection rates.

    • Impact:

    • Tolerated sting challenges significantly improve patient quality of life, especially for those at high risk of treatment failure.
    • VIT with elevated venom doses can prevent or correct treatment failure, potentially negating the need for sting challenges in some high-risk patients.
    • The study clarifies the clinical utility of sting challenges, guiding optimal management strategies for Hymenoptera venom allergy.